2025
SJR Q1
JCR Q1 · 11,5
OA
7 matched articles
SCIE
Journal detail
Journal of Neuroinflammation
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
17422094
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 3,685
- Quartile Q1
- H-Index 189
- Cites/doc 11,19
- Docs (3y) 947
- Cites (3y) 12.017
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 11,5
- 5Y JIF 12,9
- JCI 2,4
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cellular and Molecular Neuroscience Q1
- Immunology Q1
- Neurology Q1
- Neuroscience (miscellaneous) Q1
Areas
- Immunology and Microbiology
- Neuroscience
WoS categories
- Immunology | Neurosciences
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,685 | 11,5 | 12,9 | 2,4 | Q1 | 189 |
| 2024 | Q1 | Q1 | 3,183 | 10,1 | 10,9 | 2,17 | Q1 | 168 |
| 2023 | Q1 | Q1 | 2,831 | 9,3 | 9,8 | 1,93 | Q1 | 168 |
| 2022 | Q1 | Q1 | 2,439 | 9,3 | 9,8 | 1,69 | Q1 | 168 |
| 2021 | Q1 | Q1 | 2,286 | 9,6 | 9,5 | 1,61 | Q1 | 168 |
| 2020 | Q1 | Q1 | 2,615 | 8,3 | 8,2 | 1,61 | Q1 | 168 |
| 2019 | Q1 | Q1 | 2,187 | 5,8 | 6,2 | 1,49 | Q1 | 168 |
| 2018 | — | Q1 | — | 5,7 | 6 | 1,42 | Q1 | — |
| 2017 | Q1 | Q1 | 2,336 | 5,2 | 5,8 | 1,35 | Q1 | 168 |
| 2016 | Q1 | Q1 | 2,328 | 5,1 | 5,7 | — | — | 168 |
| 2015 | Q1 | Q1 | 2,515 | 4,7 | 5,4 | — | — | 168 |
| 2014 | Q1 | Q1 | 2,7 | 5,4 | 5,6 | — | — | 168 |
| 2013 | Q1 | Q1 | 2,398 | 4,9 | 5,5 | — | — | 168 |
| 2012 | Q1 | Q1 | 1,771 | 4,4 | 5,1 | — | — | 168 |
| 2011 | Q1 | Q2 | 1,836 | 3,8 | 4,7 | — | — | 168 |
| 2010 | Q1 | Q1 | 2,423 | 5,8 | — | — | — | 168 |
| 2009 | — | Q1 | — | 4,7 | — | — | — | — |
| 2008 | — | Q2 | — | 3,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q1 | Q1 | 12/183 |
| 2025 | NEUROSCIENCES | SCIE | Q1 | Q1 | 13/330 |
| 2024 | IMMUNOLOGY | SCIE | Q1 | Q1 | 14/183 |
| 2024 | NEUROSCIENCES | SCIE | Q1 | Q1 | 13/314 |
| 2023 | IMMUNOLOGY | SCIE | Q1 | Q1 | 13/181 |
| 2023 | NEUROSCIENCES | SCIE | Q1 | Q1 | 16/310 |
| 2022 | IMMUNOLOGY | SCIE | Q1 | Q1 | 21/161 |
| 2022 | NEUROSCIENCES | SCIE | Q1 | Q1 | 20/272 |
| 2021 | IMMUNOLOGY | SCIE | Q1 | Q1 | 30/162 |
| 2021 | NEUROSCIENCES | SCIE | Q1 | Q1 | 24/275 |
| 2020 | IMMUNOLOGY | SCIE | Q1 | Q1 | 21/162 |
| 2020 | NEUROSCIENCES | SCIE | Q1 | Q1 | 23/273 |
| 2019 | IMMUNOLOGY | SCIE | Q1 | Q1 | 29/159 |
| 2019 | NEUROSCIENCES | SCIE | Q1 | Q1 | 36/272 |
| 2018 | IMMUNOLOGY | SCIE | Q1 | Q1 | 30/158 |
| 2018 | NEUROSCIENCES | SCIE | Q1 | Q1 | 40/267 |
| 2017 | IMMUNOLOGY | SCIE | Q1 | Q1 | 33/155 |
| 2017 | NEUROSCIENCES | SCIE | Q1 | Q1 | 41/261 |
| 2016 | IMMUNOLOGY | SCIE | Q1 | — | 32/151 |
| 2016 | NEUROSCIENCES | SCIE | Q1 | — | 40/259 |
| 2015 | IMMUNOLOGY | SCIE | Q1 | — | 34/151 |
| 2015 | NEUROSCIENCES | SCIE | Q1 | — | 50/256 |
| 2014 | IMMUNOLOGY | SCIE | Q1 | — | 23/148 |
| 2014 | NEUROSCIENCES | SCIE | Q1 | — | 32/252 |
| 2013 | IMMUNOLOGY | SCIE | Q1 | — | 26/144 |
| 2013 | NEUROSCIENCES | SCIE | Q1 | — | 48/252 |
| 2012 | NEUROSCIENCES | SCIE | Q1 | — | 59/252 |
| 2011 | NEUROSCIENCES | SCIE | Q2 | — | 66/244 |
| 2010 | NEUROSCIENCES | SCIE | Q1 | — | 28/239 |
| 2009 | NEUROSCIENCES | SCIE | Q1 | — | 45/231 |
| 2008 | NEUROSCIENCES | SCIE | Q2 | — | 79/221 |